Farmaceutica REMEDIA Cash Flow Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	8.72	6.96	7.2	5.81	7.23	Upgrade
Depreciation & Amortization	2.41	2.63	5.06	4.02	1.11	Upgrade
Other Amortization	-	-	-	-	0.09	Upgrade
Other Operating Activities	4.52	9.37	10.96	-11.81	-5.8	Upgrade
Operating Cash Flow	15.65	18.96	23.22	-1.99	2.63	Upgrade
Operating Cash Flow Growth	-17.48%	-18.34%	-	-	-	Upgrade
Capital Expenditures	-1.33	-1.79	-1.38	-0.04	-0.04	Upgrade
Sale of Property, Plant & Equipment	0.11	0.35	0.35	0.2	0.48	Upgrade
Other Investing Activities	0.12	2.06	0.07	0.08	0.14	Upgrade
Investing Cash Flow	-1.09	0.62	-0.97	0.24	0.58	Upgrade
Repurchase of Common Stock	-0.57	-	-1.5	-	-	Upgrade
Common Dividends Paid	-3.35	-6.29	-4.19	-4.47	-13.35	Upgrade
Other Financing Activities	-0.25	-0.14	-0	-0.05	0.01	Upgrade
Financing Cash Flow	-4.17	-6.43	-5.7	-4.52	-13.35	Upgrade
Miscellaneous Cash Flow Adjustments	-	-0	-0.14	0.14	-	Upgrade
Net Cash Flow	10.39	13.16	16.41	-6.13	-10.13	Upgrade
Free Cash Flow	14.32	17.17	21.84	-2.03	2.59	Upgrade
Free Cash Flow Growth	-16.60%	-21.36%	-	-	-	Upgrade
Free Cash Flow Margin	1.88%	2.31%	3.68%	-0.38%	0.54%	Upgrade
Free Cash Flow Per Share	0.15	0.18	0.23	-0.02	0.03	Upgrade
Cash Interest Paid	-	-	-	0.07	-	Upgrade
Cash Income Tax Paid	7.3	5.31	1.61	1.29	1.55	Upgrade
Levered Free Cash Flow	18.15	19.84	21.82	1.54	10.32	Upgrade
Unlevered Free Cash Flow	18.18	19.9	21.9	1.64	10.39	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.